BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9171905)

  • 1. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    Biol Psychiatry; 1997 Jun; 41(12):1149-55. PubMed ID: 9171905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.
    Young EA; Haskett RF; Grunhaus L; Pande A; Weinberg VM; Watson SJ; Akil H
    Arch Gen Psychiatry; 1994 Sep; 51(9):701-7. PubMed ID: 8080346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-endorphin response to a low dosage of human corticotropin releasing hormone during metyrapone administration in depression.
    Lisansky J; Hauger R; Strassman R; Dorin R; Meikle AW; Brazis M; Qualls C; Turkin A
    Endocr Res; 1992; 18(4):241-60. PubMed ID: 1473519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment.
    von Bardeleben U; Stalla GK; Müller OA; Holsboer F
    Biol Psychiatry; 1988 Nov; 24(7):782-6. PubMed ID: 2852510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA; Ribeiro SC
    Brain Res; 2006 Dec; 1126(1):148-55. PubMed ID: 16824495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.
    Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1273-92. PubMed ID: 7863016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone.
    Lisansky J; Peake GT; Strassman RJ; Qualls C; Meikle AW; Risch SC; Fava GA; Zownir-Brazis M; Hochla P; Britton D
    Arch Gen Psychiatry; 1989 Jul; 46(7):641-9. PubMed ID: 2544155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.
    Ur E; Dinan TG; O'Keane V; Clare AW; McLoughlin L; Rees LH; Turner TH; Grossman A; Besser GM
    Neuroendocrinology; 1992 Oct; 56(4):533-8. PubMed ID: 1335555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol, corticotropin, and beta-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema.
    Rupprecht M; Hornstein OP; Schlüter D; Schäfers HJ; Koch HU; Beck G; Rupprecht R
    Psychoneuroendocrinology; 1995; 20(5):543-51. PubMed ID: 7675938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.
    Coste J; Strauch G; Letrait M; Bertagna X
    Br J Clin Pharmacol; 1994 Nov; 38(5):474-9. PubMed ID: 7893592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
    Inder WJ; Livesey JH; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):7-13. PubMed ID: 8706296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies.
    Young EA; Watson SJ; Kotun J; Haskett RF; Grunhaus L; Murphy-Weinberg V; Vale W; Rivier J; Akil H
    Arch Gen Psychiatry; 1990 May; 47(5):449-57. PubMed ID: 2139563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer.
    Calogero AE; Minacapilli G; Nicolosi AM; Moncada ML; Mistretta A; Latteri SF; Polosa P; D'Agata R
    J Endocrinol Invest; 1992 Sep; 15(8):581-6. PubMed ID: 1331223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.